Search Constraints
Search Results
Select an image to start the slideshow
Aberrant Proteasome Pathway in Alzheimer's Disease at Early
Stage revealed by Whole-Transcriptome Study
1 of 18
Identification and characterization of disease-associated proteins
in frontotemporal lobar degeneration
2 of 18
APOE ε4, but not diabetes, is a risk factor for
Alzheimer's Disease
3 of 18
Characterization of LR11/SorLA in Mild Cognitive Impairment
4 of 18
M1 Muscarinic Acetylcholine Receptor Signaling and Regulation ofAmyloid Precursor Protein Processing
5 of 18
Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of Alzheimer's disease
6 of 18
Characterization of the Relationship Between LR11 and Tau Pathology
7 of 18
RNA-binding proteins with mixed charge domains self-assemble, aggregate, and interact with core pathologies in Alzheimer's Disease
8 of 18
Alzheimer's Disease Associated Genomic Variants Identified in White Populations are Present in African Americans at Risk for Alzheimer's Disease Due to Family History
9 of 18
Amyloid Precursor Protein Regulation by G Protein-Coupled Receptor 12
10 of 18
Neuron-specific cellular functions of Interleukin-9 in Alzheimer’s Disease
11 of 18
Development of Region-Specific Tau Pathology in P301S Mice
12 of 18
Amplification of amyloid-beta strains and their connection to tau in Alzheimer’s Disease
13 of 18
Association between Anti-Inflammatory Interleukin-10 and Executive Function in African American Women at risk for Alzheimer's Disease
14 of 18
LCMT-1 is an essential component of neuronal development
15 of 18
Physical Activity May be a Modifiable Risk Factor for Cognitive Decline in African Americans and Caucasians at High Risk for Developing Alzheimer's Disease
16 of 18
From epigenetic memory to memory loss: How tau prevents LSD1 from regulating transcription and induces cell death in Alzheimer’s disease
17 of 18
The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Test Performance in the Congolese Population
18 of 18